Magnetic resonance imaging‐based detection of glial brain tumors in mice after antiangiogenic treatment

An Claes(Utrecht University), William P. J. Leenders(Radboud University Nijmegen), Olaf van Tellingen(Dutch Cancer Society), Bob C. Hamans(Radboud University Nijmegen), Pieter Wesseling(Radboud University Nijmegen), Giulio Gambarota(Inserm), Arend Heerschap(Radboud University Nijmegen), Cathy Maass(Radboud University Nijmegen)
International Journal of Cancer
December 14, 2007
10.1002/ijc.23306
Cited by 55

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
<scp>WHO</scp> 2016 Classification of gliomas
|Neuropathology and Applied Neurobiology|2017|817